Mega Lifesciences Public Company Limited Profit Margin

Mega Lifesciences Public Company Limited (MEGA.BK) currently reports a profit margin of 15.12% as of June 2026. That compares with 13.06% in the prior-year period — up 15.8% year over year. That is above the sector sector average of 13.23%. Use the charts on this page to explore Mega Lifesciences Public Company Limited's profit margin history and peer comparisons.

Mega Lifesciences Public Company Limited's profit margin increased from 13.06% to 15.12% — a 15.8% year-over-year increase (period ending June 2026). Watching multi-year history on the chart below helps separate one-off swings from a lasting trend.

Mega Lifesciences Public Company Limited's profit margin of 15.12% is higher than the its sector sector average of 13.23%. That is roughly 14.3% above the sector mean. A reading higher peers can reflect different growth expectations, capital structure, or profitability — so it is worth checking the peer comparison chart before drawing conclusions.

There is no universal 'good' profit margin, but Mega Lifesciences Public Company Limited's current 15.12% should be judged against industry norms (sector average: 13.23%) and against MEGA.BK's own history. Strong, stable readings often indicate durable competitive advantage; volatile or declining ones deserve a closer look at margins and capital efficiency.

Start with the current profit margin of 15.12%, then check the historical chart for trend and the peer comparison chart for relative positioning. The sector average is 13.23%. From there, open related valuation or income-statement pages for Mega Lifesciences Public Company Limited, and consider following MEGA.BK for alerts when major investors trade the stock.